Corvex-Casdin-backed SPAC Is Close to Completing an Agreement to Merge With Drug Startup EQRx - NewsBreak

The third SPAC backed by Eli Casdin's Casdin Capital LLC and Keith Meister's Corvex Management LP, CM Life Sciences III, is set to merge with the young pharmaceutical startup EQRx Inc. In a deal that could be worth up to $1.8 billion in cash, including a $1.2 billion investment from...